“Reducing hay waste and spreading/drying areas around finished bales is key to reducing stable fly numbers,” she says. “In ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal ...

Days of Our Lives spoilers and updates reveal EJ DiMera (Dan Feuerriegel) might not tell the truth about who the actual ...

A nurse who double-dosed a care home resident and then tried to frame a colleague has been struck off by the Nursing and ...

The U.S. Food and Drug Administration has granted regenerative medicine advanced therapy (RMAT) designation to Fate's FT819 ...

The High Line Canal Trail is easy to access in the Denver metro area. One entrance to the 71-mile trail is particularly ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...

FDA accepts Regeneron's sBLA for Eylea HD in RVO with priority review; QUASAR data supports monthly dosing, target action date set for August 2025.

Discover the best joint supplement in 2025 to help reduce discomfort, improve mobility, and support overall joint health with ...

The sBLA seeks approval for Eylea HD for both the treatment of macular edema following retinal vein occlusion, and for ...